Legend Biotech Corporation (LEGN)

Legend Biotech (NASDAQ:LEGN) jumped 10% amid takeover speculation.
The biotech firm received takeover interest and hired investment bank Centerview Partners to help its board to review the offer and other options, according to a Street Insider report on Friday, which cited an unidentified source. The identity of the bidder wasn't known.
Legend Biotech (LEGN) didn't respond to Street Insider and Seeking Alpha's requests for comment. Legend has a market cap of almost $9 billion.
Legend Biotech (LEGN) is set to report its Q2 results on Aug. 9.